| Catalogue | Nom | Étiquettes de produit |
| AFG-LB-03 | AffiBEAD® Anti-DYKDDDDK Immunomagnetic Beads | Anti-DYKDDDDK Immunomagnetic Beads |
| AFG-LB-05 | AffiBEAD® Anti-GFP Affinity Agarose | Anti-GFP Affinity Agarose |
| AFG-LB-06 | AffiBEAD® Anti-GFP Nanobody Affinity Agarose | Anti-GFP Nanobody Affinity Agarose |
| AFG-LB-08 | AffiBEAD® Anti-HA (YPYDVPDYA) Affinity Agarose | Anti-HA (YPYDVPDYA) Affinity Agarose |
| AFG-LB-15 | AffiBEAD® Anti-MYC (EQKLISEEDL) Affinity Agarose | Anti-MYC (EQKLISEEDL) Affinity Agarose |
| AFG-LB-10 | AffiBEAD® Anti-HA (YPYDVPDYA) Immunomagnetic Beads | Anti-HA (YPYDVPDYA) Immunomagnetic Beads |
| AFG-LB-11 | AffiBEAD® Anti-MBP Nanobody Affinity Agarose | Anti-MBP Nanobody Affinity Agarose |
| AFG-LB-12 | AffiBEAD® Anti-mCherry Nanobody Affinity Agarose | Anti-mCherry Nanobody Affinity Agarose |
| AFG-LB-02 | AffiBEAD® Anti-DYKDDDDK Affinity Agarose | Anti-DYKDDDDK Affinity Agarose |
| AFG-LB-16 | AffiBEAD® Anti-MYC (EQKLISEEDL) Immunomagnetic Beads | Anti-MYC (EQKLISEEDL) Immunomagnetic Beads |
| AFG-LB-23 | AffiBEAD® Protein A/G Affinity Agarose | Protein A/G Affinity Agarose |
| AFG-LB-07 | AffiBEAD® Anti-GFP Nanobody Immunomagnetic Beads | Anti-GFP Nanobody Immunomagnetic Beads |
| AFG-LB-13 | AffiBEAD® Anti-mCherry Nanobody Immunomagnetic Beads | Anti-mCherry Nanobody Immunomagnetic Beads |
| AFG-LB-24 | AffiBEAD® Protein A/G Magnetic Beads | Protein A/G Magnetic Beads |
Related articles
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo growth of CD8 and NK cells Using recombinant interleukin-2 (IL-2) as a therapeutic protein has been restricted by vital toxicities regardless of its demonstrated capability to induce sturdy tumor-regression in most cancers sufferers. The antagonistic occasions and restricted efficacy of IL-2 remedy are […]
Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody
Scientific Course of Euthyroid Topics With Optimistic TSH Receptor Antibody: How Typically Does Graves’ Illness Develop? Background: Thyroid stimulating hormone receptor antibody (TRAb) is detected within the serum of sufferers with Graves’ illness (GD). This examine goals to research the prevalence of euthyroid people displaying optimistic outcomes for TRAb and to make clear the medical course […]
a:0:{}
Mutational signatures influence the evolution of anti-EGFR antibody resistance in colorectal most cancers Anti-EGFR antibodies equivalent to cetuximab are lively in opposition to KRAS/NRAS wild-type colorectal cancers (CRCs), however acquired resistance invariably evolves. It’s unknown which mutational mechanisms allow resistance evolution and whether or not adaptive mutagenesis (a transient cetuximab-induced enhance in mutation era) contributes in sufferers. […]